# Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS)

> **NCT06211933** · PHASE1,PHASE2 · SUSPENDED · sponsor: **Centre Leon Berard** · enrollment: 26 (estimated)

## Conditions studied

- Non-Resectable Pancreas Carcinoma

## Interventions

- **PROCEDURE:** HIFU intervention

## Key facts

- **NCT ID:** NCT06211933
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2024-06-25
- **Primary completion:** 2028-02
- **Final completion:** 2030-02
- **Target enrollment:** 26 (ESTIMATED)
- **Why stopped:** Following a decision by the industrial partner, it was decided to permanently close the study to new participants.
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06211933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06211933, "Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06211933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*